Page 1

Changé , France , October 22 , 2021 PRESS RELEASE ņ Séché ELIGIBLE PEA PME European Rising Tech LABEL Q3 2021 activity : Contributed revenue + 14 % Spill Tech provided a solid contribution Solid business and favorable environment within main markets with organic growth of + 6 % Business targets confirmed for 2021 Séché is bringing forward its communication relating to its Q3 revenue in order to respect the equality of information between shareholders and creditors in the context of a potential refinancing in the debt capital markets . Q3 2021 activity confirms Séché's growth momentum at work for one year in its main markets and reinforces the Company's confidence in its 2021 revenue targets . With contributed revenue¹ of € 183.4 million for the third quarter of 2021 - up 14.1 % compared to Q3 2020 - Séché demonstrates its ability to benefit in the long - term from a normalized and well - oriented economy , particularly in its industrial markets , in France and in the Group's main geographies . Spill Tech contributed € 13.5 million to Q3 revenue - this sound performance reflects the successful integration of this subsidiary acquired at the beginning of 2021 and the continuation of its growth momentum at the heart of buoyant markets . At constant scope and exchange rates , the Group's business grew 5.5 % compared to Q3 2020 ( and 7.2 % compared to the same period in 2019 ) , reflecting the high - level of activity in the recovery and treatment business lines for the last year , in France and in most areas where the Group has an international presence . ¹ See Appendix 1 : " Definition of contributed revenue " In the first 9 months of 2021 , contributed revenue amounted to € 538.1 million , up 16.9 % compared to the first 9 months of 2020. € 24.6 million of the increase corresponds to the strong contribution of Spill Tech , a South African subsidiary acquired at the start of the year and included in the consolidation scope from March 1 , 2021 . At constant scope and exchange rates , contributed revenue over the first 9 months of 2021 grew by 11.4 % ( and 13.7 % compared to the first 9 months of 2019 ) , evidence of the Group's ongoing growth phase in its main markets within the recovery and treatment sectors in France and abroad .